Potential Blockbusters From AstraZeneca And Lilly Now Under EMA Review

 
• By Francesca Bruce
  
The European Medicines Agency has started reviewing new marketing authorization applications. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from EMA